Electrophysiological abnormalities of the neuromuscular transmission in two patients with botulism-like syndrome following Botulinum-A muscle injections

Neurophysiol Clin. 2024 Jul;54(4):102984. doi: 10.1016/j.neucli.2024.102984. Epub 2024 May 17.

Abstract

Botulinum neurotoxin serotype A (BoNT-A) has several therapeutic indications such as spasticity and dystonia. Although its use is generally considered safe, a systemic diffusion can lead to systemic complications, and a botulism-like syndrome can occur after intramuscular injections. Herein, two adult cases who developed general muscle weakness after a BoNT-A intramuscular injection are reported. Both presented with a progressive decrement on low-frequency (LF) repetitive nerve stimulation (RNS). It is suggested that a progressive decrement on LF-RNS in muscles distant from the injection site strongly supports the diagnosis of iatrogenic botulism.

Keywords: Botulism; Decrement; Electroneuromyography; RNS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Botulinum Toxins, Type A* / adverse effects
  • Botulism* / diagnosis
  • Humans
  • Injections, Intramuscular / adverse effects
  • Muscle Weakness / etiology
  • Neuromuscular Agents / adverse effects
  • Neuromuscular Junction / drug effects
  • Neuromuscular Junction / physiopathology
  • Synaptic Transmission / drug effects

Substances

  • Botulinum Toxins, Type A
  • Neuromuscular Agents